Tag: M.W:200-300

The three-dimensional configuration of the ester heterocycle is basically the same as that of the carbocycle. Compound: (S)-tert-Butyl 2-methyl-3-oxopiperazine-1-carboxylate(SMILESS: O=C(N1[C@@H](C)C(NCC1)=O)OC(C)(C)C,cas:1799971-34-8) is researched.Recommanded Product: 5,5′-Dimethyl-2,2′-bipyridine. The article 《Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists》 in relation to this compound, is published in Bioorganic & Medicinal Chemistry Letters. Let’s take a look at the latest research on this compound (cas:1799971-34-8).

The optimization efforts that led to a novel series of Me substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones that are potent rat and human P2X7 antagonists are described. These efforts resulted in the discovery of compounds with good drug-like properties that are capable of high P2X7 receptor occupancy in rat following oral administration, including compounds I (P2X7 IC50 = 7.7 nM) and II (P2X7 IC50 = 7.7 nM). These compounds are expected to be useful tools for characterizing the effects of P2X7 antagonism in models of depression and epilepsy, and several of the compounds prepared are candidates for effective P2X7 PET tracers.

Compounds in my other articles are similar to this one((S)-tert-Butyl 2-methyl-3-oxopiperazine-1-carboxylate)Computed Properties of C10H18N2O3, you can compare them to see their pros and cons in some ways,such as convenient, effective and so on.

Reference:
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem

Rudolph, Dale A.; Alcazar, Jesus; Ameriks, Michael K.; Anton, Ana Belen; Ao, Hong; Bonaventure, Pascal; Carruthers, Nicholas I.; Chrovian, Christa C.; De Angelis, Meri; Lord, Brian; Rech, Jason C.; Wang, Qi; Bhattacharya, Anindya; Andres, Jose Ignacio; Letavic, Michael A. published the article 《Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists》. Keywords: dihydrotriazolopyrazinylmethanone preparation purinoceptor antagonist antidepressant anticonvulsant; 5,6-Dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones; CNS; Depression; P2X7.They researched the compound: (S)-tert-Butyl 2-methyl-3-oxopiperazine-1-carboxylate( cas:1799971-34-8 ).Recommanded Product: (S)-tert-Butyl 2-methyl-3-oxopiperazine-1-carboxylate. Aromatic heterocyclic compounds can be divided into two categories: single heterocyclic and fused heterocyclic. In addition, there is a lot of other information about this compound (cas:1799971-34-8) here.

The optimization efforts that led to a novel series of Me substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones that are potent rat and human P2X7 antagonists are described. These efforts resulted in the discovery of compounds with good drug-like properties that are capable of high P2X7 receptor occupancy in rat following oral administration, including compounds I (P2X7 IC50 = 7.7 nM) and II (P2X7 IC50 = 7.7 nM). These compounds are expected to be useful tools for characterizing the effects of P2X7 antagonism in models of depression and epilepsy, and several of the compounds prepared are candidates for effective P2X7 PET tracers.

In some applications, this compound(1799971-34-8)Recommanded Product: (S)-tert-Butyl 2-methyl-3-oxopiperazine-1-carboxylate is unique.If you want to know more details about this compound, you can contact with the author or consult more relevant literature.

Reference:
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem

The three-dimensional configuration of the ester heterocycle is basically the same as that of the carbocycle. Compound: (S)-tert-Butyl 2-methyl-3-oxopiperazine-1-carboxylate(SMILESS: O=C(N1[C@@H](C)C(NCC1)=O)OC(C)(C)C,cas:1799971-34-8) is researched.Computed Properties of C12H12N2. The article 《Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists》 in relation to this compound, is published in Bioorganic & Medicinal Chemistry Letters. Let’s take a look at the latest research on this compound (cas:1799971-34-8).

The optimization efforts that led to a novel series of Me substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones that are potent rat and human P2X7 antagonists are described. These efforts resulted in the discovery of compounds with good drug-like properties that are capable of high P2X7 receptor occupancy in rat following oral administration, including compounds I (P2X7 IC50 = 7.7 nM) and II (P2X7 IC50 = 7.7 nM). These compounds are expected to be useful tools for characterizing the effects of P2X7 antagonism in models of depression and epilepsy, and several of the compounds prepared are candidates for effective P2X7 PET tracers.

I hope my short article helps more people learn about this compound((S)-tert-Butyl 2-methyl-3-oxopiperazine-1-carboxylate)Application of 1799971-34-8. Apart from the compound(1799971-34-8), you can read my other articles to know other related compounds.

Reference:
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem

Most of the compounds have physiologically active properties, and their biological properties are often attributed to the heteroatoms contained in their molecules, and most of these heteroatoms also appear in cyclic structures. A Journal, Article, Bioorganic & Medicinal Chemistry Letters called Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists, Author is Rudolph, Dale A.; Alcazar, Jesus; Ameriks, Michael K.; Anton, Ana Belen; Ao, Hong; Bonaventure, Pascal; Carruthers, Nicholas I.; Chrovian, Christa C.; De Angelis, Meri; Lord, Brian; Rech, Jason C.; Wang, Qi; Bhattacharya, Anindya; Andres, Jose Ignacio; Letavic, Michael A., which mentions a compound: 1799971-34-8, SMILESS is O=C(N1[C@@H](C)C(NCC1)=O)OC(C)(C)C, Molecular C10H18N2O3, Electric Literature of C10H18N2O3.

The optimization efforts that led to a novel series of Me substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones that are potent rat and human P2X7 antagonists are described. These efforts resulted in the discovery of compounds with good drug-like properties that are capable of high P2X7 receptor occupancy in rat following oral administration, including compounds I (P2X7 IC50 = 7.7 nM) and II (P2X7 IC50 = 7.7 nM). These compounds are expected to be useful tools for characterizing the effects of P2X7 antagonism in models of depression and epilepsy, and several of the compounds prepared are candidates for effective P2X7 PET tracers.

From this literature《Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists》,we know some information about this compound(1799971-34-8)Electric Literature of C10H18N2O3, but this is not all information, there are many literatures related to this compound(1799971-34-8).

Reference:
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem

Synthetic Route of C10H18N2O3. The fused heterocycle is formed by combining a benzene ring with a single heterocycle, or two or more single heterocycles. Compound: (S)-tert-Butyl 2-methyl-3-oxopiperazine-1-carboxylate, is researched, Molecular C10H18N2O3, CAS is 1799971-34-8, about Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists. Author is Rudolph, Dale A.; Alcazar, Jesus; Ameriks, Michael K.; Anton, Ana Belen; Ao, Hong; Bonaventure, Pascal; Carruthers, Nicholas I.; Chrovian, Christa C.; De Angelis, Meri; Lord, Brian; Rech, Jason C.; Wang, Qi; Bhattacharya, Anindya; Andres, Jose Ignacio; Letavic, Michael A..

The optimization efforts that led to a novel series of Me substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones that are potent rat and human P2X7 antagonists are described. These efforts resulted in the discovery of compounds with good drug-like properties that are capable of high P2X7 receptor occupancy in rat following oral administration, including compounds I (P2X7 IC50 = 7.7 nM) and II (P2X7 IC50 = 7.7 nM). These compounds are expected to be useful tools for characterizing the effects of P2X7 antagonism in models of depression and epilepsy, and several of the compounds prepared are candidates for effective P2X7 PET tracers.

Compound(1799971-34-8)Synthetic Route of C10H18N2O3 received a lot of attention, and I have introduced some compounds in other articles, similar to this compound((S)-tert-Butyl 2-methyl-3-oxopiperazine-1-carboxylate), if you are interested, you can check out my other related articles.

Reference:
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem

Safety of (S)-tert-Butyl 2-methyl-3-oxopiperazine-1-carboxylate. Aromatic compounds can be divided into two categories: single heterocycles and fused heterocycles. Compound: (S)-tert-Butyl 2-methyl-3-oxopiperazine-1-carboxylate, is researched, Molecular C10H18N2O3, CAS is 1799971-34-8, about Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists. Author is Rudolph, Dale A.; Alcazar, Jesus; Ameriks, Michael K.; Anton, Ana Belen; Ao, Hong; Bonaventure, Pascal; Carruthers, Nicholas I.; Chrovian, Christa C.; De Angelis, Meri; Lord, Brian; Rech, Jason C.; Wang, Qi; Bhattacharya, Anindya; Andres, Jose Ignacio; Letavic, Michael A..

The optimization efforts that led to a novel series of Me substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones that are potent rat and human P2X7 antagonists are described. These efforts resulted in the discovery of compounds with good drug-like properties that are capable of high P2X7 receptor occupancy in rat following oral administration, including compounds I (P2X7 IC50 = 7.7 nM) and II (P2X7 IC50 = 7.7 nM). These compounds are expected to be useful tools for characterizing the effects of P2X7 antagonism in models of depression and epilepsy, and several of the compounds prepared are candidates for effective P2X7 PET tracers.

Compound(1799971-34-8)Safety of (S)-tert-Butyl 2-methyl-3-oxopiperazine-1-carboxylate received a lot of attention, and I have introduced some compounds in other articles, similar to this compound((S)-tert-Butyl 2-methyl-3-oxopiperazine-1-carboxylate), if you are interested, you can check out my other related articles.

Reference:
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem

The preparation of ester heterocycles mostly uses heteroatoms as nucleophilic sites, which are achieved by intramolecular substitution or addition reactions. Compound: (S)-tert-Butyl 2-methyl-3-oxopiperazine-1-carboxylate( cas:1799971-34-8 ) is researched.Name: (S)-tert-Butyl 2-methyl-3-oxopiperazine-1-carboxylate.Rudolph, Dale A.; Alcazar, Jesus; Ameriks, Michael K.; Anton, Ana Belen; Ao, Hong; Bonaventure, Pascal; Carruthers, Nicholas I.; Chrovian, Christa C.; De Angelis, Meri; Lord, Brian; Rech, Jason C.; Wang, Qi; Bhattacharya, Anindya; Andres, Jose Ignacio; Letavic, Michael A. published the article 《Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists》 about this compound( cas:1799971-34-8 ) in Bioorganic & Medicinal Chemistry Letters. Keywords: dihydrotriazolopyrazinylmethanone preparation purinoceptor antagonist antidepressant anticonvulsant; 5,6-Dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones; CNS; Depression; P2X7. Let’s learn more about this compound (cas:1799971-34-8).

The optimization efforts that led to a novel series of Me substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones that are potent rat and human P2X7 antagonists are described. These efforts resulted in the discovery of compounds with good drug-like properties that are capable of high P2X7 receptor occupancy in rat following oral administration, including compounds I (P2X7 IC50 = 7.7 nM) and II (P2X7 IC50 = 7.7 nM). These compounds are expected to be useful tools for characterizing the effects of P2X7 antagonism in models of depression and epilepsy, and several of the compounds prepared are candidates for effective P2X7 PET tracers.

Here is a brief introduction to this compound(1799971-34-8)Name: (S)-tert-Butyl 2-methyl-3-oxopiperazine-1-carboxylate, if you want to know about other compounds related to this compound(1799971-34-8), you can read my other articles.

Reference:
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem

Related Products of 65094-22-6, The transformation of simple hydrocarbons into more complex and valuable products via catalytic C–H bond functionalisation has revolutionised modern synthetic chemistry. 65094-22-6, Name is Diethyl (bromodifluoromethyl)phosphonate, SMILES is CCOP(=O)(OCC)C(F)(F)Br, belongs to benzodioxans compound. In a article, author is Dettbarn, WD, introduce new discover of the category.

The contribution of carboxylesterase (CarbE) to toxicity and tolerance to the organophosphorus anticholinesterases; (OP-antiChE) paraoxon (diethyl p-nitrophenyl phosphate) and DFP (diisopropylphosphorofluoridate) was investigated in rats. Daily injections (20 days) of paraoxon (0.33 mu mol/kg) or DFP (2.72 mu mol/kg) reduced AChE activity in brain to 29 or 16% and in diaphragm to 58 or 54%, respectively. The animals tolerated an accumulated 6-fold LD50 dose and survived an LD90 dose of carbachol, indicating tolerance to this cholinergic agonist. A single dose of paraoxon or DFP significantly reduced CarbE activity of plasma, lung and liver. After paraoxon, rapid recovery was seen of plasma and liver CarbE while recovery after DFP was much slower. Daily pretreatment with the CarbE inhibitors CBDP (2-[o-cresyl]-4H-1,2,3-benzodioxa- phosphorin-2-oxide) (7.22 mu mol/kg, s.c.) or iso-OMPA (tetraisopropylpyrophosphoramide) (8.76 mu mol/kg, i.p.), followed by paraoxon (0.33 mu mol/kg, s.c.) 30 min later, prevented the development of tolerance to paraoxon and potentiated its toxicity. Rats died on day four of the combined treatment. The CarbE inhibitors neither potentiated the DFP toxicity, nor prevented tolerance development to DFP. We conclude that rat plasma CarbE provides a significant protection against paraoxon toxicity because its rapid reactivation can reduce the toxicity of repeated paraoxon applications and thus contribute to tolerance development. This same mechanism does not apply to DFP toxicity, as inhibition of CarbE of plasma, liver and lung neither potentiated its toxicity, nor prevented tolerance development. These findings confirm previous observations that CarbE detoxification is of greater importance for highly toxic OP-antiChEs such as nerve agents and paraoxon than for less toxic ones such as DFP. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.

Related Products of 65094-22-6, Each elementary reaction can be described in terms of its molecularity, the number of molecules that collide in that step. The slowest step in a reaction mechanism is the rate-determining step.you can also check out more blogs about 65094-22-6.

Reference:
Benzodioxan,
,1,4-Benzodioxane | C8H8O2 – PubChem

Some examples of the diverse research done by chemistry experts include discovery of new medicines and vaccines, improving understanding of environmental issues, and development of new chemical products and materials. Electric Literature of 214894-89-0, In a article, mentioned the application of 214894-89-0, Name is 5-(Bromomethyl)-2,3-dihydro-1,4-benzodioxine, molecular formula is C9H9BrO2

In recent years solid evidence of HAT reactions involving water as hydrogen atom source have been presented. In this work we demonstrate that the efficiency of titanocene(III) aqua complexes as an unique class of HAT reagents is based on two key features: (a) excellent binding capabilities of water toward titanocene(III) complexes and (b) a low activation energy for the HAT step. The theory has predictive capabilities fitting well with the experimental results and may aid to find more examples of this remarkable radical reaction.

We very much hope you enjoy reading the articles and that you will join us to present your own research about 214894-89-0 . Electric Literature of 214894-89-0

Reference：
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem

Reference of 214894-89-0, In chemical reaction engineering, simulations are useful for investigating and optimizing a particular reaction process or system. 214894-89-0, Name is 5-(Bromomethyl)-2,3-dihydro-1,4-benzodioxine,introducing its new discovery.

A simple method has been developed for the cross dehydrogenative coupling between two different primary alcohols using readily available RuCl2(PPh3)3 as a precatalyst through the borrowing-hydrogen approach. The present methodology is applicable to a large variety of alcohol derivatives including long chain aliphatic alcohols and heteroaryl alcohols. In addition, the methodology was applied in a straightforward protocol to synthesize commercially available fragrances such as Rosaphen and Cyclamenaldehyde in good yields.

Reference of 214894-89-0, You can also check out more blogs about Reference of 214894-89-0!

Reference：
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem